Free Trial

Rocket Pharmaceuticals (RCKT) Insider Trading & Ownership

Rocket Pharmaceuticals logo
$13.98 -0.84 (-5.67%)
(As of 11/15/2024 ET)

Rocket Pharmaceuticals (NASDAQ:RCKT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
28.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$11.85 M
Get RCKT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Rocket Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RCKT Insider Buying and Selling by Quarter

Rocket Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/22/2024John MilitelloInsiderSell812$23.02$18,692.24  
7/8/2024Mark Andrew WhiteInsiderSell3,026$20.39$61,700.14  
5/16/2024Gaurav ShahCEOSell9,790$23.35$228,596.50  
5/16/2024John MilitelloInsiderSell1,079$23.35$25,194.65  
5/16/2024Martin WilsonGeneral CounselSell1,048$23.35$24,470.80  
4/22/2024John MilitelloInsiderSell833$22.87$19,050.71  
4/15/2024David P SouthwellDirectorSell10,000$24.05$240,500.00  
4/12/2024David P SouthwellDirectorSell70,000$24.36$1,705,200.00  
4/8/2024Mark Andrew WhiteInsiderSell12,532$24.64$308,788.48  
3/21/2024Gotham MakkerDirectorSell274,000$28.43$7,789,820.00  
3/21/2024John MilitelloInsiderSell2,490$28.10$69,969.00  
2/29/2024John MilitelloInsiderSell10,000$29.84$298,400.00  
2/29/2024Martin WilsonGeneral CounselSell4,100$29.33$120,253.00  
2/16/2024Gaurav ShahCEOSell20,272$29.84$604,916.48  
2/16/2024Kinnari PatelInsiderSell7,132$29.84$212,818.88  
2/16/2024Martin WilsonGeneral CounselSell3,576$29.84$106,707.84  
1/22/2024John MilitelloInsiderSell638$27.20$17,353.60  
(Data available from 1/1/2013 forward)

RCKT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Rocket Pharmaceuticals includes David P Southwell, Gaurav Shah, Gotham Makker, John Militello, Jonathan David Schwartz, Kinnari Patel, Mark Andrew White, Martin Wilson, and Rtw Investments, Lp. Learn more on insiders at RCKT.

28.50% of Rocket Pharmaceuticals stock is owned by insiders. Learn more on RCKT's insider holdings.

The following insiders have sold RCKT shares in the last 24 months: David P Southwell ($1,945,700.00), Gaurav Shah ($1,139,676.11), Gotham Makker ($8,457,281.36), John Militello ($512,864.53), Jonathan David Schwartz ($67,796.42), Kinnari Patel ($236,549.86), Mark Andrew White ($370,488.62), and Martin Wilson ($251,431.64).

Insiders have sold a total of 487,171 Rocket Pharmaceuticals shares in the last 24 months for a total of $12,981,788.54 sold.

Rocket Pharmaceuticals Key Executives

  • Ms. Kinnari Patel M.B.A. (Age 44)
    Pharm.D., Head of R&D, President & COO
    Compensation: $849.93k
  • Mr. Mayo Pujols (Age 54)
    Chief Technical Officer
    Compensation: $649.71k
  • Mr. Raj Prabhakar M.B.A. (Age 49)
    Chief Business Officer
    Compensation: $619.13k
  • Mr. Aaron Ondrey (Age 47)
    Chief Financial Officer
  • Mr. Martin Louis Wilson J.D. (Age 48)
    General Counsel, Chief Compliance Officer & Chief Corporate Officer
    Compensation: $149.95k
  • Kevin Giordano
    Director of Corporate Communications
  • Ms. Isabel Carmona J.D.
    Chief People Officer
  • Mr. Jonathan Schwartz M.D. (Age 59)
    Chief Medical & Gene Therapy Officer
    Compensation: $557.79k
  • Dr. Gayatri R. Rao J.D.
    M.D., Senior VP of Clinical Safety & Chief Regulatory Officer
  • Mr. Carlos Martin
    Chief Commercial Operations & Revenue Officer


This page (NASDAQ:RCKT) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners